6BrCaQ
6BrCaQ is a potent mitochondrial heat shock protein TRAP1 inhibitor, with antiproliferative activity. 6BrCaQ can be used in the synthesis of 6BrCaQ-TPP conjugates.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 954416-67-2
- Formule: C18H15BrN2O3
- Masse moléculaire:387.23
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Caco-2 | IC50 |
8 μM
Compound: 6BrCaQ
|
Antiproliferative activity against human Caco2 cells assessed as inhibition of cell proliferation
Antiproliferative activity against human Caco2 cells assessed as inhibition of cell proliferation
|
[PMID: 24992077] |
| HT-29 | IC50 |
20 μM
Compound: 6BrCaQ
|
Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
Cytotoxicity against human HT-29 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay
|
[PMID: 34952432] |
| IGROV-1 | IC50 |
5 μM
Compound: 6BrCaQ
|
Antiproliferative activity against human IGROV1 cells assessed as inhibition of cell proliferation
Antiproliferative activity against human IGROV1 cells assessed as inhibition of cell proliferation
|
[PMID: 24992077] |
| Ishikawa | IC50 |
2 μM
Compound: 6BrCaQ
|
Antiproliferative activity against human Ishikawa cells assessed as inhibition of cell proliferation
Antiproliferative activity against human Ishikawa cells assessed as inhibition of cell proliferation
|
[PMID: 24992077] |
| LP-1 | GI50 |
6.2 μM
Compound: 6BrCaQ
|
Growth inhibition of human LP-1 cells after 72 hrs by MTS assay
Growth inhibition of human LP-1 cells after 72 hrs by MTS assay
|
[PMID: 24992077] |
| MCF7 | GI50 |
7 μM
Compound: 6BrCaQ
|
Growth inhibition of ER-positive human MCF7 cells after 72 hrs by MTT assay
Growth inhibition of ER-positive human MCF7 cells after 72 hrs by MTT assay
|
[PMID: 24992077] |
| MCF7 | IC50 |
7 μM
Compound: 6BrCaQ
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation
|
[PMID: 24992077] |
| MCF7 | IC50 |
7 μM
Compound: 6BrCaQ
|
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth
Cytotoxicity against human MCF7 cells assessed as inhibition of cell growth
|
[PMID: 34952432] |
| MDA-MB-231 | GI50 |
0.06 μM
Compound: 6BrCaQ
|
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 72 hrs by Celltiter Glo assay
Cytotoxicity against human MDA-MB-231 cells assessed as cell growth inhibition incubated for 72 hrs by Celltiter Glo assay
|
[PMID: 34952432] |
| MDA-MB-231 | GI50 |
2 μM
Compound: 6BrCaQ
|
Growth inhibition of ER-negative human MDA-MB-231 cells after 72 hrs by MTT assay
Growth inhibition of ER-negative human MDA-MB-231 cells after 72 hrs by MTT assay
|
[PMID: 24992077] |
| MDA-MB-231 | IC50 |
2 μM
Compound: 6BrCaQ
|
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell proliferation
Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell proliferation
|
[PMID: 24992077] |
| PC-3 | GI50 |
10 μM
Compound: 6BrCaQ
|
Growth inhibition of human PC3 cells after 72 hrs by MTS assay
Growth inhibition of human PC3 cells after 72 hrs by MTS assay
|
[PMID: 24992077] |
| RPMI-8226 | GI50 |
5 μM
Compound: 6BrCaQ
|
Growth inhibition of human RPMI8226 cells after 72 hrs by MTS assay
Growth inhibition of human RPMI8226 cells after 72 hrs by MTS assay
|
[PMID: 24992077] |
Chemical Information
-
CAS No. 954416-67-2
-
Masse moléculaire 387.23
-
Formule C18H15BrN2O3
-
SMILES
COC1=CC=C(C=C1)C(NC2=CC3=CC(Br)=CC=C3N(C2=O)C)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)